Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments

Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has released a recast of financial information following a strategic segment realignment of its reporting segments, focusing on Aptar Closures and Aptar Beauty. The recast covers the past two years of performance for these segments, while the financials for Aptar Pharma remain unchanged. The detailed financial information is accessible in the company's Form 8-K filed on April 13, 2023. Aptar is recognized for its innovative solutions in drug delivery, consumer product dispensing, and active material sciences, catering to various industries including pharmaceuticals and beauty. Headquartered in Crystal Lake, Illinois, Aptar employs 13,500 people across 20 countries.

Positive

• Recast financial information enhances clarity for investors regarding the performance of Aptar Closures and Aptar Beauty segments.
• The strategic segment realignment may lead to improved focus and resource allocation within the company.

Negative

• None.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment of two of its business reporting segments.

The financial information reflects the past two years of recast performance for Aptar’s two realigned reporting segments, Aptar Closures and Aptar Beauty. Aptar Pharma’s financial statements are unchanged.

The recast financial information can be found in the company’s April 13, 2023 Form 8-K.

About Aptar

Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,500 dedicated employees in 20 countries. For more information, visit www.aptar.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230413005647/en/

Investor Relations Contact:

Mary Skafidas

mary.skafidas@aptar.com

+1 347-351-6407

Media Contact:

Katie Reardon

katie.reardon@aptar.com

+1 815-479-5671

Source: AptarGroup, Inc.

FAQ

What is AptarGroup's recent financial announcement regarding segment realignment?

AptarGroup announced a recast of financial information due to the realignment of its business reporting segments, specifically Aptar Closures and Aptar Beauty.

How has AptarGroup's segment reporting changed?

Aptar's segment reporting has been realigned to better reflect the performance of Aptar Closures and Aptar Beauty, affecting the financial information for the past two years.

Where can I find the recast financial information for AptarGroup?

The recast financial information is available in AptarGroup's Form 8-K filed on April 13, 2023.

Does AptarGroup's financial data for Aptar Pharma change?

No, the financial statements for Aptar Pharma remain unchanged despite the realignment of other segments.